Amy W. Schulman
Director · ALNYLAM PHARMACEUTICALS, INC.
- 2025
- May 22, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Amy W. Schulman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Yvonne Greenstreet - $16.95M in ALNY purchases and sales in the last 12 months
- Kevin Joseph Fitzgerald - $8.24M in ALNY purchases and sales in the last 12 months
- Pushkal Garg - $4.88M in ALNY purchases and sales in the last 12 months
- Jeffrey V. Poulton - $2.22M in ALNY purchases and sales in the last 12 months
- Tolga Tanguler - $1.88M in ALNY purchases and sales in the last 12 months
- Melissa McLaughlin - $1.27M in ALNY purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Amy W. Schulman?
Amy W. Schulman is a corporate insider, tracked as Director of ALNYLAM PHARMACEUTICALS, INC. (ALNY). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Amy W. Schulman last file a Form 4?
The most recent primary Form 4 on record is dated 22 May 2026, one of 6 filings going back to 2025.
Has Amy W. Schulman been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($7K) across all tracked filings.
